Scope of the Medical Marijuana Market report: Make an inquiry for purchasing this report The companies have been profiled in terms of their strategic outlook, product portfolio, and SWOT assessment.
The key players profiled in the report are GW Pharmaceuticals, Aphria, Aurora Cannabis Inc., Canopy Growth Corporation, Medical Marijuana, Inc., Supreme Cannabis Company Inc., MedReleaf, CanniMed Therapeutics Inc., Lexaria Corporation, Tilray, United Cannabis Corporation, Emerald Health Therapeutics, Cannabis Sativa, Inc., Cronos Group, GBSciences, Inc., The Hydropothecary Corporation, Corbus Pharmaceuticals, Namaste Technologies, and Insys Therapeutics, Inc. Presence of prominent marijuana companies in the region is also expected to drive the regional share. The country has completely legalized the sale, production, & consumption of medical marijuana and is thus witnessing robust product sales. In terms of the regional landscape, Canada medical marijuana industry is projected to witness 32% CAGR over 2018-2024. Request for a sample of this research report Powered by the increasing number of dispensaries set up in myriad regions and growth in the legal sale of medical marijuana have optimistically influenced and proliferated the segment growth. The rising inclination toward marijuana as opposed to opioid narcotics will also influence the industry trends.Īccording to the report, medical marijuana market size from dispensaries is foreseen to exhibit a double-digit CAGR of 36.2% over 2018-2024. The extensive demand for marijuana in the treatment of chronic pain due to cancer, arthritis, HIV/AIDS, and cancer will foster the global medical marijuana market growth. report featuring key industry trends across the application, route of administration, distribution channel, and regional landscape.
Global Medical Marijuana Market outlook is projected to surpass USD 55 billion by 2024, says a new Global Market Insights, Inc.